国药一致 - Financials

国药一致 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	74.4B	75.5B	73.4B	68.4B	59.6B
Revenue Growth %	-1.5%	2.8%	7.4%	14.6%	--
Total Revenue	74.4B	75.5B	73.4B	68.4B	59.6B
Cost Of Revenue	66.1B	66.4B	64.5B	60.3B	52.6B
+Gross Profit	8.2B	9.1B	8.9B	8.0B	7.1B
Gross Margin %	11.1%	12.0%	12.2%	11.7%	11.8%
Total Operating Cost	74.1B	73.4B	71.4B	66.8B	57.8B
Selling Expenses	5.4B	5.3B	5.3B	4.8B	3.9B
Admin Expenses	1.1B	1.1B	1.1B	1.0B	1.0B
Rd Expenses	24.6M	26.8M	9.1M	--	--
Finance Expenses	239.0M	205.0M	190.0M	212.0M	120.0M
+Operating Income	573.0M	2.5B	2.3B	2.0B	2.2B
Operating Margin %	0.8%	3.3%	3.1%	2.9%	3.6%
Non Operating Income	29.4M	24.5M	12.5M	36.4M	17.7M
Non Operating Expenses	27.4M	18.7M	7.5M	13.9M	24.3M
Investment Income	242.0M	237.0M	139.0M	292.0M	284.0M
Fair Value Change Income	-20.7M	-15.2M	28.9M	--	--
Asset Disposal Income	11.9M	45.3M	8.3M	4.2M	6.8M
Asset Impairment Loss	995.0M	17.6M	71.6M	243.0M	5.2M
Other Income	73.3M	94.4M	89.5M	103.0M	72.4M
Income Before Tax	575.0M	2.5B	2.3B	2.0B	2.2B
Income Tax	338.0M	515.0M	539.0M	447.0M	436.0M
+Net Income	237.0M	2.0B	1.8B	1.5B	1.7B
Net Margin %	0.3%	2.6%	2.4%	2.2%	2.9%
Net Income Attributable	642.0M	1.6B	1.5B	1.3B	1.4B
Minority Interest	-405.0M	359.0M	285.0M	191.0M	319.0M
Eps Basic	1.15	2.87	2.67	3.12	3.27
Eps Diluted	1.15	2.87	2.67	3.12	3.27

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	7.4B	6.5B	6.0B	5.1B	6.0B
Trading Financial Assets	--	--	--	--	--
Accounts Receivable	19.4B	18.2B	13.8B	16.0B	13.8B
Notes Receivable	657.0M	1.1B	1.1B	680.0M	622.0M
Notes And Accounts Receivable	20.0B	19.3B	14.9B	16.6B	14.4B
Prepayments	692.0M	620.0M	844.0M	521.0M	480.0M
Inventory	7.4B	8.0B	7.8B	7.6B	6.3B
Total Current Assets	37.6B	36.4B	31.7B	31.8B	29.3B
Long Term Equity Investment	2.9B	2.7B	2.6B	2.5B	2.3B
Fixed Assets	--	866.0M	850.0M	869.0M	854.0M
Fixed Assets Total	870.0M	866.0M	850.0M	869.0M	854.0M
Construction In Progress	--	35.4M	35.2M	49.8M	46.6M
Construction In Progress Total	12.6M	35.4M	35.2M	49.8M	46.6M
Intangible Assets	480.0M	616.0M	648.0M	670.0M	734.0M
Long Term Deferred Expenses	468.0M	527.0M	573.0M	634.0M	458.0M
Total Non Current Assets	10.0B	11.2B	10.9B	10.9B	10.3B
Total Assets	47.6B	47.6B	42.6B	42.8B	39.6B
Short Term Borrowings	3.0B	2.6B	1.3B	1.9B	1.6B
Accounts Payable	9.6B	9.6B	8.2B	9.1B	7.7B
Advance Receipts	18.7M	18.2M	18.3M	19.3M	12.4M
Contract Liabilities	331.0M	438.0M	569.0M	431.0M	369.0M
Total Current Liabilities	24.8B	24.3B	21.0B	22.4B	20.3B
Long Term Borrowings	--	--	17.5M	71.6M	31.6M
Total Non Current Liabilities	2.0B	2.3B	2.1B	2.4B	2.4B
Total Liabilities	26.8B	26.6B	23.2B	24.8B	22.7B
Paid In Capital	557.0M	557.0M	428.0M	428.0M	428.0M
Capital Reserve	4.3B	4.3B	4.4B	4.4B	4.4B
Surplus Reserve	278.0M	278.0M	214.0M	214.0M	214.0M
Retained Earnings	12.6B	12.3B	11.1B	9.9B	8.9B
Minority Equity	3.1B	3.6B	3.3B	3.1B	2.9B
Equity Attributable	17.7B	17.4B	16.1B	14.9B	13.9B
Total Equity	20.8B	21.0B	19.4B	18.0B	16.9B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	79.4B	77.7B	80.9B	71.6B	61.7B
Tax Refunds Received	7.7M	23.0M	25.1M	13.5M	13.7M
Total Operating Cash Inflow	80.4B	78.6B	81.7B	72.3B	63.4B
Cash Paid For Goods	69.8B	67.9B	72.1B	63.9B	56.0B
Cash Paid To Employees	3.5B	3.7B	3.5B	3.4B	2.7B
Taxes Paid	1.8B	1.9B	1.8B	1.6B	1.5B
Total Operating Cash Outflow	77.1B	75.6B	79.1B	70.7B	61.9B
Operating Cash Flow	3.3B	2.9B	2.6B	1.7B	1.5B
Total Investing Cash Inflow	217.0M	201.0M	181.0M	173.0M	212.0M
Total Investing Cash Outflow	368.0M	337.0M	523.0M	629.0M	3.0B
Investing Cash Flow	-151.0M	-135.0M	-343.0M	-456.0M	-2.8B
Cash From Borrowings	1.6B	1.9B	1.5B	933.0M	802.0M
Dividends And Interest Paid	671.0M	664.0M	656.0M	673.0M	614.0M
Debt Repayments	1.6B	1.8B	1.5B	1.0B	427.0M
Total Financing Cash Inflow	1.8B	2.1B	1.9B	1.1B	1.2B
Total Financing Cash Outflow	3.7B	4.5B	3.5B	2.9B	2.9B
Financing Cash Flow	-1.8B	-2.4B	-1.5B	-1.9B	-1.7B
Net Change In Cash	1.3B	393.0M	709.0M	-672.0M	-3.0B
Ending Cash Balance	7.1B	5.8B	5.4B	4.7B	5.4B
Capex	283.0M	322.0M	322.0M	370.0M	294.0M